Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yogesh S Jethava

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Transplantation and Cellular Therapy|August 28, 2025
CAR T Therapy in B-Cell NHL: A Transformative Advance, However Several Clinical And Financial Challenges RemainYogesh S Jethava
Cancer Treatment and Research|October 4, 2016
Transplantation for Multiple MyelomaYogesh S Jethava, Frits van Rhee
The New England Journal of Medicine|July 6, 2017
Drug Combinations with Transplantation for MyelomaYogesh S Jethava, Bart Barlogie, Guido J Tricot
Blood Advances|January 4, 2018
The impact of prior malignancies on second malignancies and survival in MM patients: a population-based studyGudbjörg Jonsdottir, Sigrún H Lund, Magnus Björkholm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2016
Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan TransplantsYogesh S Jethava, Alan Mitchell, Joshua Epstein, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Transplantation and Cellular Therapy|August 28, 2025
CAR T Therapy in B-Cell NHL: A Transformative Advance, However Several Clinical And Financial Challenges RemainYogesh S Jethava
Cancer Treatment and Research|October 4, 2016
Transplantation for Multiple MyelomaYogesh S Jethava, Frits van Rhee
The New England Journal of Medicine|July 6, 2017
Drug Combinations with Transplantation for MyelomaYogesh S Jethava, Bart Barlogie, Guido J Tricot
Blood Advances|January 4, 2018
The impact of prior malignancies on second malignancies and survival in MM patients: a population-based studyGudbjörg Jonsdottir, Sigrún H Lund, Magnus Björkholm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2016
Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan TransplantsYogesh S Jethava, Alan Mitchell, Joshua Epstein, et al.
Pageof 1